title: [Effectiveness of mexitil-depot in patients with chronic ventricular arrhythmia].
abstract: Bacterial bronchial asthma provokes development of secondary immunodeficiency. In addition to conventional treatment 90 asthmatics were given standard doses of timogen and myelopid alone and in combination. Routine clinical and immunological tests show that the above medication corrects immunodeficiency and advances the efficacy of the basic treatment. In combination, timogen and myelopid displayed the highest efficacy.
authors.forename: A P
authors.initials: AP
authors.lastname: Golikov
authors.forename: E N
authors.initials: EN
authors.lastname: Botolova
authors.forename: D V
authors.initials: DV
authors.lastname: Rudnev
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D004562:Electrocardiography; D015716:Electrocardiography, Ambulatory; D005260:Female; D006801:Humans; D008297:Male; D008801:Mexiletine / Q000008:administration & dosage*; D008875:Middle Aged; D013997:Time Factors; D018879:Ventricular Premature Complexes / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000889:Anti-Arrhythmia Agents; D003692:Delayed-Action Preparations; D008801:Mexiletine
vernacular_title: Effektivnost' meksitila-depo u bol'nykh s khronicheskoĭ zheludochkovoĭ aritmieĭ.